STUDIES ON THE CLINICAL PHARMACOLOGY OF PRAZOSIN. I: CARDIOVASCULAR, CATECHOLAMINE AND ENDOCRINE CHANGES FOLLOWING A SINGLE DOSERUBIN PC; BLASCHKE TF.1980; BRIT. J. CLIN. PHARMACOL.; GBR; DA. 1980; VOL. 10; NO 1; PP. 23-32; BIBL. 36 REF.Article

HEPATIC FIRST-PASS METABOLISM IN LIVER DISEASEBLASCHKE TF; RUBIN PC.1979; CLIN. PHARMACOKINET.; NLD; DA. 1979; VOL. 4; NO 6; PP. 423-432; BIBL. 2 P.Article

VITAMIN K₁, VITAMIN K₁ EPOXIDE AND WARFARIN INTERRELATIONSHIPS IN THE DOGCARLISLE DM; BLASCHKE TF.1981; BIOCHEM. PHARMACOL.; ISSN 0006-2952; GBR; DA. 1981; VOL. 30; NO 21; PP. 2931-2936; BIBL. 17 REF.Article

CALCULATION OF DRUG CONCENTRATION IN PLASMA AFTER EQUILIBRIUM DIALYSISGIACOMINI KM; ABANG A; BLASCHKE TF et al.1982; BR. J. CLIN. PHARMACOL.; ISSN 0306-5251; GBR; DA. 1982; VOL. 14; NO 5; PP. 752-753Article

EFFECT OF NALOXONE: A SPECIFIC OPIOID INHIBITOR ON BLOOD PRESSURE FALL DURING SLEEPRUBIN P; BLASCHKE TF; GUILLEMINAULT C et al.1981; CIRCULATION; ISSN 0009-7322; USA; DA. 1981; VOL. 63; NO 1; PP. 117-121; BIBL. 22 REF.Article

DEFECTIVE BROMOSULFO-PHTHALEIN CLEARANCE IN PATIENTS WITH CONSTITUTIONAL HEPATIC DYSFUNCTION (GILBERT'S SYNDROME) = CHUTE DE LA CLEARANCE DE LA BROMOSULFONEPHTALEINE CHEZ DES MALADES ATTEINTS DE PERTURBATIONS FONCTIONNELLES HEPATIQUES CONSTITUTIONNELLES (SYNDROME DE GILBERT)BERK PD; BLASCHKE TF; WAGGONER JG et al.1972; GASTROENTEROLOGY; U.S.A.; DA. 1972; VOL. 63; NO 3; PP. 472-481; BIBL. 1P.Serial Issue

COMPARATIVE ANTICHOLINERGIC POTENCIES OF R- AND S-DISOPYRAMIDE IN LONGITUDINAL MUSCLE STRIPS FROM GUINEA PIG ILEUMGIACOMINI KM; COX BM; BLASCHKE TF et al.1980; LIFE SCI. (1973); ISSN 0024-3205; GBR; DA. 1980; VOL. 27; NO 13; PP. 1191-1197; BIBL. 8 REF.Article

ATENOLOL DETERMINATION BY HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY AND FLUORESCENCE DETECTIONYEE YG; RUBIN P; BLASCHKE TF et al.1979; J. CHROMATOGR.; NLD; DA. 1979; VOL. 171; PP. 357-362; BIBL. 5 REF.Article

DISPOSITION OF ACETONE FOLLOWING ACUTE ACETONE INTOXICATIONRAMU A; ROSENBAUM J; BLASCHKE TF et al.1978; WEST. J. MED.; USA; DA. 1978; VOL. 129; NO 5; PP. 429-432; BIBL. 10 REF.Article

HIGH-PRESSURE LIQUID CHROMATOGRAPHIC ANALYSIS OF DRUGS IN BIOLOGICAL FLUIDS. I. WARFARIN.BJORNSSON TD; BLASCHKE TF; MEFFIN PJ et al.1977; J. PHARM. SCI.; U.S.A.; DA. 1977; VOL. 66; NO 1; PP. 142-144; BIBL. 11 REF.Article

HIGH-PRESSURE LIQUID CHROMATOGRAPHIC ANALYSIS OF DRUGS IN BIOLOGICAL FLUIDS. IV. DETERMINATION OF CLOFIBRINIC ACID.BJORNSSON TD; BLASCHKE TF; MEFFIN PJ et al.1977; J. CHROMATOGR.; NETHERL.; DA. 1977; VOL. 137; NO 1; PP. 145-152; BIBL. 13 REF.Article

MEASUREMENT OF FUROSEMIDE BY HIGH-PERFORMANCE LIQUID CHROMATOGRAPHYSWEZEY SE; MEFFIN PJ; BLASCHKE TF et al.1979; J. CHROMATOGR.; NLD; DA. 1979; VOL. 174; NO 2; PP. 469-473; BIBL. 7 REF.Article

THE EFFECT OF SATURABLE BINDING TO PLASMA PROTEINS ON THE PHARMACOKINETIC PROPERTIES OF DISOPYRAMIDEGIACOMINI KM; SWEZEY SE; TURNER TAMIYASU K et al.1982; J. PHARMACOKINET. BIOPHARM.; ISSN 0090-466X; USA; DA. 1982; VOL. 10; NO 1; PP. 1-14; BIBL. 23 REF.Article

EFFECT OF PHENOBARBITONE ON THE DISPOSITION OF LIGNOCAINE AND WARFARIN IN THE DOGESQUIVEL M; BLASCHKE TF; SNIDOW GH et al.1978; J. PHARM. PHARMACOL.; GBR; DA. 1978; VOL. 30; NO 12; PP. 804-805; BIBL. 8 REF.Article

ADMINISTRATION OF HEPARIN CAUSES IN VITRO RELEASE OF NON-ESTERIFIED FATTY ACIDS IN HUMAN PLASMAGIACOMINI KM; SWEZEY SE; GIACOMINI JC et al.1980; LIFE SCI. (1973); ISSN 0024-3205; GBR; DA. 1980; VOL. 27; NO 9; PP. 771-780; BIBL. 21 REF.Article

INFLUENCE OF ACUTE VIRAL HEPATITIS ON PHENYTOIN KINETICS AND PROTEIN BINDING = ROLE DE L'HEPATITE VIRALE AIGUE SUR LA PHARMACOCINETIQUE DE LA PHENYTOINE ET SA LIAISON AUX PROTEINES PLASMATIQUESBLASCHKE TF; MEFFIN PJ; MELMON KL et al.1975; CLIN. PHARMACOL. THERAPEUT.; U.S.A.; DA. 1975; VOL. 17; NO 6; PP. 685-691; BIBL. 1P.1/2Article

SALIVA AND PLASMA LEVELS AND PLASMA PROTEIN BINDING OF CLOFIBRINIC ACID IN UREMIC PATIENTSBJORNSSON TD; MEFFIN PJ; PETERS FA et al.1980; CLIN. PHARMACOL. THERAPEUT.; USA; DA. 1980; VOL. 27; NO 2; PP. 230-235; BIBL. 23 REF.Article

CLOFIBRATE DISPLACES WARFARIN FROM PLASMA PROTEINS IN MAN: AN EXAMPLE OF A PURE DISPLACEMENT INTERACTIONBJORNSSON TD; MEFFIN PJ; SWEZEY S et al.1979; J. PHARMACOL. EXPER. THERAPEUT.; USA; DA. 1979; VOL. 210; NO 3; PP. 316-321; BIBL. 32 REF.Article

PROBENECID INHIBITION OF METHOTREXATE EXCRETION FROM CEREBROSPINAL FLUID IN DOGSRAMU A; GLAUBIGER D; RAMU NP et al.1978; J. PHARMACOKINET. BIOPHARMACEUT.; GBR; DA. 1978; VOL. 6; NO 5; PP. 389-397; BIBL. 23 REF.Article

INFLUENCE OF ACUTE VIRAL HEPATITIS ON DISPOSITION AND PLASMA BINDING OF TOLBUTAMIDE.WILLIAMS RL; BLASCHKE TF; MEFFIN PJ et al.1977; CLIN. PHARMACOL. THERAPEUT.; U.S.A.; DA. 1977; VOL. 21; NO 3; PP. 301-309; BIBL. 1 P. 1/2Article

APPLICATION OF SALIVARY CONCENTRATION DATA TO PHARMACOKINETIC STUDIES WITH ANTIPYRINE.MEFFIN PJ; WILLIAMS RL; BLASCHKE TF et al.1977; J. PHARM. SCI.; U.S.A.; DA. 1977; VOL. 66; NO 1; PP. 135-137; BIBL. 23 REF.Article

INFLUENCE OF VIRAL HEPATITIS ON THE DISPOSITION OF TWO COMPOUNDS WITH HIGH HEPATIC CLEARANCE: LIDOCAINE AND INDOCYANINE GREEN.WILLIAMS RL; BLASCHKE TF; MEFFIN PJ et al.1976; CLIN. PHARMACOL. THERAPEUT.; U.S.A.; DA. 1976; VOL. 20; NO 3; PP. 290-299; BIBL. 1 P. 1/2Article

LIDOCAINE BLOOD CONCENTRATIONS DURING FIBEROPTIC BRONCHOSCOPY. = C SANGUINES DE LIDOCAINE AU COURS DE LA FIBROBRONCHOSCOPIEPATTERSON JR; BLASCHKE TF; HUNT KK JR et al.1975; AMER. REV. RESP. DIS.; U.S.A.; DA. 1975; VOL. 112; NO 1; PP. 53-57; BIBL. 16 REF.Article

DISPOSITION OF KETOCONAZOLE, AN ORAL ANTIFUNGAL, IN HUMANSBRASS C; GALGIANI JN; BLASCHKE TF et al.1982; ANTIMICROB. AGENTS CHEMOTHER.; ISSN 0066-4804; USA; DA. 1982; VOL. 21; NO 1; PP. 151-158; BIBL. 8 REF.Article

THE STEREOSELECTIVE DISPOSITION OF DISOPYRAMIDE IN THE DOGGIACOMINI KM; GIACOMINI JC; SWEZEY SE et al.1980; J. CARDIOVASC. PHARMACOL.; ISSN 0160-2446; USA; DA. 1980; VOL. 2; NO 6; PP. 825-832; BIBL. 11 REF.Article